Navigation Links
ANGIOGUARD® Capture Guidewire

ProductsANGIOGUARD® Capture Guidewire
Company Cordis Corporation
Item ANGIOGUARD® Capture Guidewire
Features 
  • Stroke Reduction: Polyurethane membrane with 100 pores captures clinically relevant emboli.
  • Self-Centering: The unique umbrella design centers in the vessel. Two angiograms are not required to verify wall apposition.
  • Reliable Wall Apposition: Eight Nitinol struts keep the symmetric basket in contact with the arterial wall, and help ensure debris does not escape.
  • Excellent Crossability: Profile as low as 3.2F facilitates crossing difficult lesions.
Description The Cordis ANGIOGUARD® Capture Guidewire is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures.
Info Cordis Corporation
Customer Service: (800) 327-7714
Web site: http://www.cordis.com/

Related medicine products :

1. GT-Capture
2. TTI Medical Medicap Still Image Capture
3. EyeCap SL Pro Image Capture and Management System
4. EyeCap RI Image Capture and Management System
5. EyeCap SL Image Capture and Management System
6. EyeCap FA Image Capture and Management System
7. West Nile Virus IgM Capture DxSelect
8. West Nile Virus IgG Capture DxSelect
9. West Nile Detect™ IgM Capture ELISA
10. West Nile Virus IgM Capture ELISA
11. Hybrid Capture® 2 High-Risk HPV DNA Test®
Sterile, Coil Packed Suction Catheter Mini Tray with (2) Walleted SAFESKIN PURPLE NITRILE Latex-Free Exam Gloves
These economy suction kits include a Tri-Flo® suction catheter, a pop-up solution basin and one or two sturdy, precuffed vinyl exam gloves, without inner wallet. Infant and pediatric kits with 5/
Each tray kit includes a Tri-Flo® suction catheter, two powder-free vinyl gloves in an inner wallet and a rigid basin. Infant and pediatric kits (5/6, 8 and 10 Fr) feature depth markings. 100 kit
Each kit includes a Tri-Flo® suction catheter, 4-oz. sterile saline solution for flushing and lubrication, two latex-free nitrile gloves in an inner wallet and a rigid basin. Infant and pediatric
Medicine Products:
(Date:12/3/2008)... Conn., Dec. 3 Medical device manu...to comply with the new requirements of the,amende...e effect in March,2010, a newly released Nerac wh... or increasing share in the growing $86 billion,m...f most U.S. medical device,companies, profits," w...
(Date:12/3/2008)...GH, Dec. 3 InteGreat, a MED3OOO co...roups, IPAs, and multi-specialty,clinics, recentl...der (ASP),agreement with WVVA HealthCare Alliance... the physicians in the network. , The WVVA ...ty physicians,and specialists in the Alleghany Hi...
(Date:12/3/2008)... improves quality of life, lowers stress, study fi...s) -- While asthma breathing exercises can improve...e need for inhalers, according to a study by Scott...tudy included nearly 200 adults being treated for ...of the patients did three sessions of breathing ex...
(Date:12/3/2008)...elines are aimed at combating less responsible use...c. 3 (HealthDay News) -- Expensive, sham stem cel... patients over the Internet, experts say. , In ...ientists on Wednesday issued guidelines to steer r... uses. , "Stem cell research is progressing so ...
Breaking Medicine News(10 mins):Health News:New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper 2Health News:New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper 3Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 2Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 3Health News:WVVA HealthCare Alliance Signs 14-Year ASP EHR Agreement 4Health News:Bogus Stem Cell Therapies Sold on Internet 2Health News:Bogus Stem Cell Therapies Sold on Internet 3
... wounds, a new study says//. Phillip Marucha, and ...icago in a study of laboratory mice, found that ps...ayed the closing of wounds by more than 45 percent...rekalert.org. A range of cell and genetic changes...
...re itchy and swollen, rather than being tender//. ...l Center, tenderness may be a sign the bug bite is...tion. Other signs of possible infection are rednes...diate bug bite, drainage of pus, or worsening, rat...
...nerative and ultimately fatal disease// that slowl...mer's disease sufferers lose the ability to take c... of their everyday living. Based on findings of a ...xture of peptides derived from colostrum could hel...
... again thought ways to deter their toddlers// from...annels, but how many are right for viewing by chil...ow, adding parents is a scientific that can help t...hing TV. Other than helping them for educational p...
Other Medicine News:Health News:Stop Watching TV: Toddler Development Affected 2
(Date:11/30/2008)...re-USNewswire/ -- Abnormalities in auditory and la...h autism spectrum disorder by using magnetoencepha...ay at the annual meeting of the Radiological Socie... we can record the tiny magnetic fields associated...erts, Ph.D., vice chair of research in the Departm...
(Date:11/28/2008)...Newswire-FirstCall/ -- Eli Lilly and Company,(NYS... Application (sNDA) from,the U.S. Food and Drug A...l),for the management of chronic pain. Lilly plan...f 2009, adding data from a recently completed posi...knee. , The decision does not affect duloxe...
(Date:11/26/2008)... Children whose eyes ar...y increased risk of developing mental illness by e...linic study published this month in Pediatrics , t...iatrics. , , The retrospective study examin...smus (misaligned eyes) and compared them with reco...
(Date:11/26/2008)...jects , , FRANKLIN, Mass., Nov. 26 /PRNewsw...oard: PLCSF) announced today that it has received ...ration (FDA) for its U.S. pivotal trial to study t...m(TM) and associated therapy in the prevention of...e FDA also approved PLC,s request to expand their ...
Breaking Medicine Technology:Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit of Use Compounding Kits 1946 1CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit of Use Compounding Kits 1946 2CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit of Use Compounding Kits 1946 3People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID 1944 1People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID 1944 2People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID 1944 3People With Chronic Conditions Experience Additional Benefits of Cost Savings by Wearing a Medical ID 1944 4Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board 801 1Highlights of Economic and Business Growth in the Tampa Bay Region 800 1Highlights of Economic and Business Growth in the Tampa Bay Region 800 2Highlights of Economic and Business Growth in the Tampa Bay Region 800 3Highlights of Economic and Business Growth in the Tampa Bay Region 800 4
... BROOMFIELD, Colo., June 11, 2007 /PRNewswire/ --...n-label extension of its Phase,IIb clinical trial ...t the Alzheimer,s Association,s International Conf...C. Consistent with the,findings of earlier clinica... safe and to significantly improve the memory and,...
... BRANFORD, Conn.--(BUSINESS WIRE)--Jun 11, 2007 - ...d that data from previous,Phase 1 clinical studies...reatment of insomnia, were presented today at the ...sional Sleep Societies,(APSS) in Minneapolis, Minn...n chronic insomnia patients are currently being,co...
Other Medicine Technology:Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data Presented at Associated,Professional Sleep Societies Annual Meeting 4